hrs-4508
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2024 (NCT06598735)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07232849 | Phase 2 | Nov 30, 2025 | Hengrui Therapeutics, Inc. |
| NCT07003321 | Phase 2 | Sep 12, 2025 | Hengrui Therapeutics, Inc. |
| NCT06598735 | Phase 1 | Sep 30, 2024 | Hengrui Therapeutics, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 3 | 3 | 2 | 2024 |
1 organizations
Page 1 / 1